Fingolimod trials for Multiple sclerosis

All Fingolimod trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying Fingolimod for Multiple sclerosis

• Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
  NCT04480853 · Phase: Phase 4 · Ages: 20 Years to 100 Years · Sex: All (male and female) · 6 locations
• Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
  NCT07220252 · Phase: Phase 2, Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
  NCT06408259 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 33 locations

Common questions

How many trials study Fingolimod for Multiple sclerosis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.